ITI-1284 10 mg, ITI-1284 20 mg — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03-16 in 4mo
ESTIMATED |
READOUT
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet
Phase 2 · Generalized Anxiety Disorder |
Intra-Cellular Therapies, Inc. | ITI-1284 10 mg, ITI-1284 20 mg |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-03
Sponsor-projected date — can change
|